Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescein-guided resection of glioblastoma (FLEGME)
NCT03291977Phase 3Completed
- Sponsor
- CHU Rennes
- Start
- Oct 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluorescein sodium 10% injection in glioblastoma (GBM), sponsored by CHU Rennes. Started Oct 2017; status: completed.
02
Drugs
fluorescein sodium 10% injection
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT03291977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291977.